石四药集团(02005.HK)酒石酸托特罗定缓释胶囊(4mg)获药品生产注册批件

Core Viewpoint - The company, Stone Four Pharmaceutical Group, has received production registration approval from the National Medical Products Administration of China for its sustained-release capsules of Trospium Chloride (4mg), marking it as the third domestic company to obtain such approval [1] Group 1 - The approved product, Trospium Chloride sustained-release capsules, is classified as a Class 4 chemical drug and is considered to have passed the consistency evaluation [1] - The primary indication for Trospium Chloride sustained-release capsules is the treatment of overactive bladder syndrome [1]